Biobanking Congress 2015, Toronto, InterContinental Toronto Centre, July 14-16, 2015
Reporter: Aviva Lev-Ari, PhD, RN
Cambridge Healthtech Institute’s Seventh International Leaders in Biobanking Congress: Maximizing Your Investment in Biospecimens addresses both the business and science of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge biomedical research.
KEYNOTE SESSION: IT TAKES A VILLAGE
The Complexity of Pathologist Responsibilities as Custodians of Biospecimens
Sylvia L. Asa, M.D., Ph.D., Pathologist-in-Chief, Medical Director, Laboratory Medicine Program, University Health Network; Lakeridge Health &
Women’s College Hospital; Senior Scientist, Ontario Cancer Institute; Professor, Laboratory Medicine & Pathobiology, University of Toronto
Discovery and Implementation Using EHR-Linked Biobanks: The eMERGE Experience
Rex L. Chisholm, Ph.D., Vice Dean, Scientific Affairs and Graduate Education; Adam and Richard T. Lind Professor, Medical Genetics, Northwestern
University Feinberg School of Medicine
Preparing Research Samples for Future Use: Innovative Methods for Assessing Functional Quality Control and Biobanking Best Practices
Andrew Brooks, Ph.D., COO, RUCDR Infinite Biologics; Associate Professor, Genetics, Rutgers University
Generating Comprehensive Standard Operating Procedures for a Biorepository Network – The CTRNet Experience
Brent Schacter, M.D., FRCPC, Principal Investigator, CTRNet; Professor, Department of Internal Medicine, Section of Hematology/
Oncology, College of Medicine, University of Manitoba/CancerCare Manitoba
MAINTAINING A QUALITY BIOBANK
Development and Implementation of a National Biospecimen Collection Network in a Community Hospital System
Jeffrey Otto, MBA, Ph.D., National Director, Center for Translational Research, Institute for Research and Innovation, Catholic Health Initiatives
Inventory Management; Re-Organization, Consolidation, Quality Assurance and the Cost of Space in the Biorepository
Sherilyn J. Sawyer, Ph.D., Director, BWH/Harvard Cohorts Biorepository, Channing Division of Network Medicine, Brigham and Women’s Hospital
Is There a Web-Based Solution to the Challenge of Informed Consent and Re-Consent of Legacy Biobank Samples?
Daniel B. Thiel, Public Health Researcher, Health Services Organization and Policy, University of Michigan School of Public Health
Tissue Banking, Bioinformatics and EMRs: The Front-End Requirements for Personalized Medicine
K. Stephen Suh, Ph.D., Director, Genomics and Biomarkers Program, John Theurer Cancer Center, Hackensack University Medical Center
PANEL DISCUSSION: Ensuring Biobank Value through Effective Utilization
Moderators:
Marianne K. Henderson, MS, CPC, Chief, Division of Cancer Epidemiology & Genetics, Office of Division Operations and Analysis and the Center for
Global Health, National Cancer Institute; Chair, Organizing Advisory Committee, ISBER
Marianna J. Bledsoe, MA, Adjunct Assistant Professor, Department of Clinical Research and Leadership, George Washington University School of
Medicine and Health Sciences; Co-Chair, Science Policy Committee, ISBER
Panelists:
Jeffrey Otto, MBA, Ph.D., National Director, Center for Translational Research, Institute for Research and Innovation, Catholic Health Initiatives
Sherilyn J. Sawyer, Ph.D., Director, BWH/Harvard Cohorts Biorepository, Channing Division of Network Medicine, Brigham and Women’s Hospital
K. Stephen Suh, Ph.D., Director, Genomics and Biomarkers Program, John Theurer Cancer Center, Hackensack University Medical Center
Daniel B. Thiel, Public Health Researcher, Health Services Organization and Policy, University of Michigan School of Public Health
Additional Panelists to be Announced
BIOSAMPLES, BIOMARKERS AND CLINICAL TRIALS
FEATURED PRESENTATION :
TRANSLATING PRECISION MEDICINE STRATEGY INTO OUTCOME THROUGH CLINICAL TRIALS
Lillian L. Siu, M.D., FRCPC, Professor, University of Toronto; Medical Oncologist, Princess Margaret Cancer Centre
Obtaining Biospecimens for Correlative Studies in Multi-Centre Lymphoma Clinical Trials
Koren Mann, Ph.D., Assistant Professor, Oncology, Lady Davis Institute for Medical Research, McGill University
Case Study #1: Biospecimen Sciences, Clinical Trials and Precision Medicine: Examples from Our Practice
Michael H. A. Roehrl, M.D., Ph.D., Director, UHN Program in BioSpecimen Sciences, University Health Network and University of Toronto
Anthony M. Joshua, MBBS, Ph.D., Staff Oncologist/Affiliate Scientist, Princess Margaret Cancer Centre
TOOLS TO ACCESS BIOSPECIMEN QUALITY
From Research to Clinic: (Pre-)Analytical Variables and Assay Development
Veronique Neumeister, M.D., Laboratory Director, Specialized Translational Services Lab, Department of Pathology, Yale University School of Medicine
Experimental Animal Models to Inform Human Biobanking Practices
Galen Hostetter, M.D., FCAP, Associate Director, Pathology Core, Van Andel Research Institute
Freezing under Pressure: A New Method for Cryopreservation
Nickolas Greer, CSO, Rissali LLC
Microfluidic Evaluation of Red Cells Collected and Stored in Modified Processing Solutions Used in Blood Banking
Dana Spence, Ph.D., Associate Professor, Department of Chemistry, Michigan State University
FEATURED PRESENTATION:
PRE-ANALYTICAL VARIABLES IMPACTING PERIPHERAL BLOOD SAMPLES FOR IMMUNE MONITORING IN MULTICENTER STUDIES
Amit Bar-Or, M.D., FRCPC, Professor, Neurology & Neurosurgery; Director, Experimental Therapeutics Program and Scientific Director, Clinical Research
Unit, Montreal Neurological Institute, McGill University
CASE STUDIES: BIOBANKER/BIOUSER PARTNERSHIPS
Biomedical researchers and drug developers require accessible, highquality biospecimens that allow them to extract reliable and useful data.
Oncology experts, for instance, use patient-derived tumor collections to connect datasets, pinpoint and assess variants within cancer patients
post-diagnosis and zero in on the data that matter when tailoring therapies. Early, strategic collaborations with the biobanks that house
specimens can be mutually beneficial, maximizing the financial and technological investments of the operation managers who collect, store,
annotate and distribute the biological samples (“biobankers”) and supporting the research goals of the scientists who need those samples
(“biousers”) – all to fulfill the promise of personalized medicine.
SPECIALTY BIOBANKS
The Future of iPSCs Biobanking
Jonathan Y.H. Loh, Ph.D., Assistant Professor, Department of Biological Sciences, National University of Singapore, A*STAR Institute of
Molecular and Cell Biology
Biobanking to Improve Cardiac Transplant Outcomes
Dawn E. Bowles, Ph.D., Assistant Professor, Department of Surgery, Division of Surgical Sciences and Co-Director, Duke Human Heart Repository
Planning and Implementing an Institutional Hospital for Children and Women: Ethical and Operational Consideration
Suzanne Vercauteren, M.D., Ph.D., FRCPC, Head, Division of Hematopathology, BC Children’s Hospital and Clinical Assistant Professor,
Pathology and Laboratory Medicine, University of British Columbia
The University Health Network Genito-Urinary (GU) BioBank
Neil Fleshner, M.D., MPH, FRCSC, Chair, Urology, Department of Surgery, University of Toronto; Head, Urology, University Health Network; Director,
GU BioBank, Princess Margaret Cancer Centre
Give Life Twice – An Overview of Canada’s National Public Cord Blood Bank
Heidi Elmoazzen, Ph.D., Director, National Public Cord Blood Bank
Toronto Lung Transplant Biobanking Project, What We Are Collecting
Sassan M. Azad, Project Manager, Clinical, Translational & Biobanking Research Office, Toronto Lung Transplant Program, Toronto General Hospital,
University Health Network
MAINTAINING A QUALITY BIOBANK WITH IT
Progress Is Bringing Together Clinical and Biorepository Data in an Expandable Research Data Repository
Maureen E. Lane, Ph.D., Assistant Professor, Medicine; Director, Hem/Onc Translational Core Laboratory, The Leukemia Biorepository and Personalized
Medicine Center, Weill Cornell Medical College
Data Bank and BioRepository for Translational and Basic Research
Annmarie Nowak, Coordinator & Director, Data Bank and Biorepository, Biobanking Systems Integration Cancer Prevention and Population Science,
Roswell Park Cancer Institute
Promoting Quality Biobanks and Biobank Quality: The CRIP Toolbox and the Metabiobank p-BioSPRE
Christina Schröder, Ph.D., Head, Metabiobanks CRIP, Fraunhofer Institute for Cell Therapy and Immunology
Register by March 20th & Save!
For sponsorship and exhibit sales information, contact:
Carolyn Benton
Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5412
Email: cbenton@healthtech.com
Healthtech.com/Biobanking
SOURCE
From: Leaders in Biobanking <kerris@healthtech.com>
Date: Fri, 06 Mar 2015 11:36:31 -0500
To: <avivalev-ari@alum.berkeley.edu>
Subject: Final Agenda Now Available
Leave a Reply